| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |